Third, we revealed that HIF1α potentially contributes to paclitaxel resistance by modulating IL-17 signaling pathway, and the HIF1α/IL17/CXCL10 axis may be related to neutrophil infiltration into HER2+ and HR− BC TME. Here, IL17A is linked to breast cancer.